- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03412097
(MIST1)-Part 1: Assessment & Feasibility of Post-Symptoms Evaluation (MIST1)
Assessing New or Worsening Symptoms (Aka Adverse Events for This Study) After Chiropractic Care at a Chiropractic Teaching Clinic: An Active Surveillance Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Healthcare systems acknowledge the importance of patient safety including the reduction of preventable adverse events (AE). For healthcare providers who perform spinal manipulation therapy (SMT), the investigation of AEs remains in its infancy for several reasons including finding a reporting system that accurately collects AEs information, varied descriptions of AE's severity and occurrence frequency and the variable natural history of musculoskeletal conditions treated by SMT. Together, these factors act together to conspire against the implementation of systematic changes in SMT application that would result in improved patient care and safety.
In addition, it is vital that patient safety training initiates at the start of a healthcare worker's career. This pilot active surveillance study was designed to assess the feasibility of collecting data on patients' self-report of symptom changes as well as interns' report at a chiropractic teaching clinic.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients at the Parker University Wellness Clinic
- Agreed to participate
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Patient Encounters That Report a New or Worsening Symptom
Time Frame: Up to 7 days post treatment - Day 0-7
|
An adverse advent is any unfavorable sign, symptom or disease temporarily associated with the treatment, whether or not caused by the treatment, specifically any worsened or new symptom reported by the patient up to one week after care.
|
Up to 7 days post treatment - Day 0-7
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Katherine A Pohlman, DC, MS, PhD, Parker University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Parker16_001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Safety
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentTerminatedPatient Empowerment | Patient Safety | Medication SafetyNetherlands
-
Anne Estrup OlesenAalborg University; University College of Northern Denmark; Aalborg KommuneRecruitingPatient Safety | Medication SafetyDenmark
-
Fundació d'investigació Sanitària de les Illes...Andalusian School of Public Health; Fundación Avedis Donabedian; IDIAP JORDI GOL and other collaboratorsNot yet recruiting
-
NHS Education for ScotlandRecruitingPatient SafetyUnited Kingdom
-
University of California, San FranciscoCompleted
-
Manuela EicherRecruitingPatient Reported Outcome Measures | Patient SafetySwitzerland
-
VA Office of Research and DevelopmentUniversity of California, San FranciscoNot yet recruiting
-
University Health Network, TorontoSunnybrook Health Sciences Centre; Sinai Health SystemCompleted
-
Johannes Gutenberg University MainzCompleted
-
Fundació d'investigació Sanitària de les Illes...Ministerio de Economía y Competitividad, SpainUnknown
Clinical Trials on active surveillance
-
University Health Network, TorontoActive, not recruiting
-
University of AlbertaCompleted
-
M.D. Anderson Cancer CenterRecruitingProstate CancerUnited States
-
Hospital Moinhos de VentoRecruiting
-
IRCCS San RaffaeleRecruiting
-
Uppsala UniversityRecruitingProstate CancerNorway, Denmark, Finland, United Kingdom, Sweden
-
Anhui Provincial HospitalZhongda Hospital; Yijishan Hospital of Wannan Medical College; Wuhu City Second...Recruiting
-
Seoul National University HospitalRecruitingProstate CancerKorea, Republic of
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; Uppsala UniversityActive, not recruiting
-
Erasmus Medical CenterActive, not recruitingEsophageal Cancer | Surgical Oncology | Neoadjuvant Chemoradiotherapy | Active SurveillanceNetherlands